Sonidegib – Friday Pop Quiz 8/26/2022
After discussion, this patient decides to proceed with treatment with sonidegib. Which of the following needs to be checked prior to initiation?
A. CK
B. Lipid levels
C. TSH
D. ALT/AST
E. CBC
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
…
After discussion, this patient decides to proceed with treatment with sonidegib. Which of the following needs to be checked prior to initiation?
A. CK
B. Lipid levels
C. TSH
D. ALT/AST
E. CBC
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology, Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about which options work best for treating Urticaria. Watch as he reveals various st … 
Psoriasis affects 2% of the world’s population and occurs in a bimodal distribution, peaking in early and late adulthood. Chronic plaque psoriasis is the most common variant and presents as well demarcated erythematous plaques with prominent white scale on the scalp and extremities.
The erythema of psoriasis varies across the spectrum of skin tones, ranging from a salmon and deep reddish … 
Linda Stein Gold, Director of Dermatology Clinical Research at Henry Ford Health System, lead us through “Acne across the ages” at the 17th Annual Women’s and Pediatric Dermatology Seminar. She busted through several acne myths, which are easily debunked with new acne medications:
Clascoterone 1% cream: it reduces sebum production in the skin! Similar to spironolactone, it is an anti-andr … 
The medication that the FDA recently approved for the treatment of this condition inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
…